Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin

Fassnacht, 2011, Epidemiology of adrenocortical carcinoma, 23 Bilimoria, 2008, Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors, Cancer, 113, 3130, 10.1002/cncr.23886 Kirschner, 2006, Emerging treatment strategies for adrenocortical carcinoma: a new hope, J Clin Endocrinol Metab, 91, 14, 10.1210/jc.2005-1739 Libé, 2007, Adrenocortical cancer: pathophysiology and clinical management, Endocr Relat Cancer, 14, 13, 10.1677/erc.1.01130 Bertherat, 2009, Pathogenesis of adrenocortical cancer, Best Pract Res Clin Endocrinol Metab, 23, 261, 10.1016/j.beem.2008.10.006 Else, 2011, Overview of genetic syndromes associated with adrenocortical cancer, 153 Gaujoux, 2011, WNT/β-catenin signaling in adrenocortical carcinoma, 263 Kim, 2008, Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex, Development, 135, 2593, 10.1242/dev.021493 Tissier, 2005, Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors, Cancer Res, 65, 7622, 10.1158/0008-5472.CAN-05-0593 Tadjine, 2008, Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD), Clin Endocrinol (Oxf), 69, 367, 10.1111/j.1365-2265.2008.03273.x Tadjine, 2008, Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas, Clin Endocrinol (Oxf), 68, 264 Gaujoux, 2011, beta-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma, Clin Cancer Res, 17, 328, 10.1158/1078-0432.CCR-10-2006 Yost, 1996, The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3, Genes Dev, 10, 1443, 10.1101/gad.10.12.1443 Behrens, 2004, The Wnt connection to tumorigenesis, Int J Dev Biol, 48, 477, 10.1387/ijdb.041815jb Klaus, 2008, Wnt signalling and its impact on development and cancer, Nat Rev Cancer, 8, 387, 10.1038/nrc2389 Bartholdi, 2009, Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes, J Med Genet, 46, 192, 10.1136/jmg.2008.061820 DeBaun, 2011, Beckwith-Wiedemann syndrome, 227 Fottner, 2011, The insulin-like growth factor system in adrenocortical growth control and carcinogenesis, 235 Giordano, 2009, Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling, Clin Cancer Res, 15, 668, 10.1158/1078-0432.CCR-08-1067 de Fraipont, 2005, Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy, J Clin Endocrinol Metab, 90, 1819, 10.1210/jc.2004-1075 Gicquel, 2001, Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors, Cancer Res, 61, 6762 Velázquez-Fernández, 2005, Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy, Surgery, 138, 1087, 10.1016/j.surg.2005.09.031 Giordano, 2003, Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis, Am J Pathol, 162, 521, 10.1016/S0002-9440(10)63846-1 Weiss, 1984, Tumor origin, progression, immunogenicity, and immunotherapy, Transplant Proc, 16, 528 Weiss, 1984, Reflections on tumor origin, immunogenicity, and immunotherapy, Cancer Immunol Immunother, 18, 1, 10.1007/BF00205391 Almeida, 2008, Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors, J Clin Endocrinol Metab, 93, 3524, 10.1210/jc.2008-0065 Barrett, 2007, NCBI GEO: mining tens of millions of expression profiles–database and tools update, Nucleic Acids Res, 35, D760, 10.1093/nar/gkl887 Almeida, 2010, Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults, J Clin Endocrinol Metab, 95, 1458, 10.1210/jc.2009-2040 Hayes, 2008, Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast, Clin Cancer Res, 14, 4038, 10.1158/1078-0432.CCR-07-4379 Bingham, 2006, Development of a steroidogenic factor 1/Cre transgenic mouse line, Genesis, 44, 419, 10.1002/dvg.20231 Shibata, 1997, Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene, Science, 278, 120, 10.1126/science.278.5335.120 Brault, 2001, Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development, Development, 128, 1253, 10.1242/dev.128.8.1253 Thorvaldsen, 2006, Developmental profile of H19 differentially methylated domain (DMD) deletion alleles reveals multiple roles of the DMD in regulating allelic expression and DNA methylation at the imprinted H19/Igf2 locus, Mol Cell Biol, 26, 1245, 10.1128/MCB.26.4.1245-1258.2006 Looyenga, 2007, Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery, Mol Endocrinol, 21, 2440, 10.1210/me.2006-0402 Kawabe, 1999, Dax-1 as one of the target genes of Ad4BP/SF-1, Mol Endocrinol, 13, 1267, 10.1210/mend.13.8.0325 Bookout, 2006, High-throughput real-time quantitative reverse transcription PCR, Curr Protoc Mol Biol, 10.1002/0471142727.mb1508s73 Bonnet, 2011, Wnt/beta-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors, J Clin Endocrinol Metab, 96, E419, 10.1210/jc.2010-1885 Masi, 2009, Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors, J Endocrinol Invest, 32, 597, 10.1007/BF03346515 Giordano, 2011, The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma, Am J Surg Pathol, 35, 471, 10.1097/PAS.0b013e31820bcf21 Berthon, 2010, Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development, Hum Mol Genet, 19, 1561, 10.1093/hmg/ddq029 Boulkroun, 2011, Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers, Endocrinology, 152, 4753, 10.1210/en.2011-1205 Allolio, 2011, Clinical presentation and initial diagnosis, 31 Purcell, 2011, HGF/c-Met related activation of beta-catenin in hepatoblastoma, J Exp Clin Cancer Res, 30, 96, 10.1186/1756-9966-30-96 Previdi, 2010, Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways, Eur J Cancer, 46, 1679, 10.1016/j.ejca.2010.02.036 Anderson, 2006, Met receptor signaling: a key effector in esophageal adenocarcinoma, Clin Cancer Res, 12, 5936, 10.1158/1078-0432.CCR-06-1208 Doghman, 2007, Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors, J Clin Endocrinol Metab, 92, 3253, 10.1210/jc.2007-0342 West, 2007, Gene expression profiling of childhood adrenocortical tumors, Cancer Res, 67, 600, 10.1158/0008-5472.CAN-06-3767 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci USA, 102, 15545, 10.1073/pnas.0506580102 Scheys, 2011, Evidence of adrenal failure in aging Dax1-deficient mice, Endocrinology, 152, 3430, 10.1210/en.2010-0986 Mizusaki, 2003, Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad, Mol Endocrinol, 17, 507, 10.1210/me.2002-0362 Wood, 2011, Adrenocortical stem and progenitor cells: unifying model of two proposed origins, Mol Cell Endocrinol, 336, 206, 10.1016/j.mce.2010.11.012 Kim, 2009, In search of adrenocortical stem and progenitor cells, Endocr Rev, 30, 241, 10.1210/er.2008-0039 Huang, 2010, Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog, Endocrinology, 151, 1119, 10.1210/en.2009-0814 King, 2009, Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages, Proc Natl Acad Sci USA, 106, 21185, 10.1073/pnas.0909471106 Hershkovitz, 2007, Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone, Endocrinology, 148, 976, 10.1210/en.2006-1100 Fodde, 2003, The multiple functions of tumour suppressors: it's all in APC, Nat Cell Biol, 5, 190, 10.1038/ncb0303-190 Libé, 2007, Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity, Clin Cancer Res, 13, 844, 10.1158/1078-0432.CCR-06-2085 Bertherat, 2006, Mechanisms of disease: adrenocortical tumors–molecular advances and clinical perspectives, Nat Clin Pract Endocrinol Metab, 2, 632, 10.1038/ncpendmet0321 Sun, 1997, Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome, Nature, 389, 809, 10.1038/39797 Weber, 1999, Postnatal overexpression of insulin-like growth factor II in transgenic mice is associated with adrenocortical hyperplasia and enhanced steroidogenesis, Endocrinology, 140, 1537, 10.1210/endo.140.4.6660 Caspary, 1999, Oppositely imprinted genes p57(Kip2) and Igf2 interact in a mouse model for Beckwith-Wiedemann syndrome, Genes Dev, 13, 3115, 10.1101/gad.13.23.3115 Kirschner, 2002, Signaling pathways in adrenocortical cancer, Ann N Y Acad Sci, 968, 222, 10.1111/j.1749-6632.2002.tb04338.x Soon, 2008, Molecular markers and the pathogenesis of adrenocortical cancer, Oncologist, 13, 548, 10.1634/theoncologist.2007-0243 Smith, 2000, Adrenal masses are associated with familial adenomatous polyposis, Dis Colon Rectum, 43, 1739, 10.1007/BF02236860 Marchesa, 1997, Adrenal masses in patients with familial adenomatous polyposis, Dis Colon Rectum, 40, 1023, 10.1007/BF02050923 Ono, 1991, A case of familial adenomatous polyposis complicated by thyroid carcinoma, carcinoma of the ampulla of vater and adrenocortical adenoma, Jpn J Surg, 21, 234, 10.1007/BF02470915 Gicquel, 1997, Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors, J Clin Endocrinol Metab, 82, 2559 Libé, 2009, Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy, J Clin Endocrinol Metab, 94, 3631, 10.1210/jc.2009-1025 Heaton, 2011, Adrenocortical stem and progenitor cells: implications for cancer, 285 Nieman, 2010, Approach to the patient with an adrenal incidentaloma, J Clin Endocrinol Metab, 95, 4106, 10.1210/jc.2010-0457 Trezzi, 2009, “Dedifferentiated” adrenal cortical neoplasm, Int J Surg Pathol, 17, 343, 10.1177/1066896909335155 Bernard, 2003, A case report in favor of a multistep adrenocortical tumorigenesis, J Clin Endocrinol Metab, 88, 998, 10.1210/jc.2002-021117 Woodson, 2004, Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women, J Natl Cancer Inst, 96, 407, 10.1093/jnci/djh042 Wolf, 1994, Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth, Endocrinology, 135, 1877, 10.1210/endo.135.5.7525257 Sakatani, 2005, Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice, Science, 307, 1976, 10.1126/science.1108080 Patterson, 2011, MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy, Cancer, 117, 1630, 10.1002/cncr.25724 Veronese, 2010, Oncogenic role of miR-483-3p at the IGF2/483 locus, Cancer Res, 70, 3140, 10.1158/0008-5472.CAN-09-4456 Veronese, 2011, Mutated beta-catenin evades a microRNA-dependent regulatory loop, Proc Natl Acad Sci USA, 108, 4840, 10.1073/pnas.1101734108